An 82-year-old man is brought to the emergency department because of severe pain and joint stiffness in his right knee. The pain started 3 days ago and has worsened despite acetaminophen intake. He has benign prostatic hyperplasia and hypertension. One week ago, he had a urinary tract infection and was treated with nitrofurantoin. He does not smoke or drink alcohol. His current medications include enalapril, hydrochlorothiazide, and tamsulosin. He appears to be in severe pain and has trouble moving his right knee. His temperature is 38.7°C (101.5°F), pulse is 92/min, and blood pressure is 135/90 mm Hg. Physical examination shows a swollen, erythematous, warm right knee; range of motion is limited by pain. Synovial fluid aspiration shows a yellow-green turbid fluid. Gram stain of the synovial aspirate shows numerous leukocytes and multiple gram-negative rods. An x-ray of the right knee shows no abnormalities. Which of the following is the most appropriate pharmacotherapy?
Q52
A 64-year-old woman with a past medical history of poorly managed diabetes presents to the emergency department with nausea and vomiting. Her symptoms started yesterday and have been progressively worsening. She is unable to eat given her symptoms. Her temperature is 102°F (38.9°C), blood pressure is 115/68 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for left-sided costovertebral angle tenderness, and urinalysis demonstrates bacteriuria and pyuria. The patient is admitted to the hospital and started on IV ceftriaxone. On day 3 of her hospital stay she is afebrile, able to eat and drink, and feels better. Which of the following antibiotic regimens should be started or continued as an outpatient upon discharge?
Q53
A 51-year-old man presents to his physician’s office with a persistent fever that started a week ago. He says that his temperature ranges between 37.8–39.1°C (100–102.5°F). He has also had a persistent cough productive of foul-smelling sputum. There is no significant medical history to report, but he does mention that he has been suffering from dental caries for the last month. He has been meaning to see his dentist but has been too busy to do so. His blood pressure is 120/70 mm Hg, the respirations are 18/min, and the temperature is 38.5°C (101.3°F). His oxygen saturation is 90% on room air. On examination, he has decreased breath sounds in his right lung field with the presence of soft inspiratory crackles. He is sent to the laboratory for sputum analysis and chest imaging. Based on his history and physical examination, which of the following would be the next best step in the management of this patient?
Q54
A 37-year-old man with a history of IV drug use presents to the ED with complaints of fevers, chills, and malaise for one week. He admits to recently using IV and intramuscular heroin. Vital signs are as follows: T 40.0 C, HR 120 bpm, BP 110/68 mmHg, RR 14, O2Sat 98%. Examination reveals a new systolic murmur that is loudest at the lower left sternal border. Initial management includes administration of which of the following regimens?
Q55
A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?
Q56
A 26-year-old immigrant from Mexico presents to your clinic for a physical. He tells you that several weeks ago, he noticed a lesion on his penis which went away after several weeks. It was nontender and did not bother him. He currently does not have any complaints. His temperature is 97.9°F (36.6°C), blood pressure is 139/91 mmHg, pulse is 87/min, respirations are 14/min, and oxygen saturation is 98% on room air. Physical exam is unremarkable and shows no evidence of any rash. A VDRL and FTA-ABS test are both positive. What is the most appropriate management of this patient?
Q57
A 51-year-old man comes to the physician because of a 1-day history of progressive pain, excessive tearing, and blurry vision of his right eye. He first noticed his symptoms last evening while he was watching a movie at a theater. His left eye is asymptomatic. He wears contact lenses. He has atopic dermatitis treated with topical hydrocortisone. His temperature is 37°C (98.6°F), pulse is 85/min, and blood pressure is 135/75 mm Hg. Examination shows a visual acuity in the left eye of 20/25 and 20/40 in the right eye. The right eye shows conjunctival injection and an edematous cornea with a whitish exudate at the bottom of the anterior chamber. Fluorescein staining shows a round corneal infiltrate. Which of the following is the most appropriate pharmacotherapy?
Q58
A 36-year-old woman comes to the emergency department because of an itchy lesion on her skin. The rash developed shortly after she took an antibiotic for a urinary tract infection. Her temperature is 37.5°C (99.3°F), pulse is 99/min, and blood pressure is 100/66 mm Hg. Physical examination shows swelling of the face and raised, erythematous plaques on her trunk and extremities. Which of the following is the most likely cause of this patient's current condition?
Q59
Six days after undergoing an elective hip replacement surgery, a 79-year-old man develops dysuria, flank pain, and fever. His temperature is 38.5°C (101.3°F). Examination shows marked tenderness in the right costovertebral area. Treatment with an antibiotic is begun, but his symptoms do not improve. Further evaluation shows that the causal organism produces an enzyme that inactivates the antibiotic via phosphorylation. An agent from which of the following classes of antibiotics was most likely administered?
Q60
A 51-year-old man with alcohol use disorder comes to the physician because of a fever and productive cough. An x-ray of the chest shows a right lower lobe consolidation and a diagnosis of aspiration pneumonia is made. The physician prescribes a drug that blocks peptide transfer by binding to the 50S ribosomal subunit. Which of the following drugs was most likely prescribed?
Antibiotics US Medical PG Practice Questions and MCQs
Question 51: An 82-year-old man is brought to the emergency department because of severe pain and joint stiffness in his right knee. The pain started 3 days ago and has worsened despite acetaminophen intake. He has benign prostatic hyperplasia and hypertension. One week ago, he had a urinary tract infection and was treated with nitrofurantoin. He does not smoke or drink alcohol. His current medications include enalapril, hydrochlorothiazide, and tamsulosin. He appears to be in severe pain and has trouble moving his right knee. His temperature is 38.7°C (101.5°F), pulse is 92/min, and blood pressure is 135/90 mm Hg. Physical examination shows a swollen, erythematous, warm right knee; range of motion is limited by pain. Synovial fluid aspiration shows a yellow-green turbid fluid. Gram stain of the synovial aspirate shows numerous leukocytes and multiple gram-negative rods. An x-ray of the right knee shows no abnormalities. Which of the following is the most appropriate pharmacotherapy?
A. IV ceftazidime and gentamicin
B. IV cefepime (Correct Answer)
C. IV vancomycin and ceftazidime
D. IV vancomycin
E. IV nafcillin
Explanation: ***IV cefepime***
- This patient presents with **septic arthritis** due to **gram-negative rods**, likely originating from a recent **urinary tract infection** given his history of BPH. **Cefepime** is a **fourth-generation cephalosporin** with broad-spectrum activity against many gram-negative bacteria, including *Pseudomonas aeruginosa*, and provides excellent coverage for this suspected etiology.
- The patient's presentation with **fever**, a **hot, swollen, painful joint**, and **turbid synovial fluid** with **numerous leukocytes** and **gram-negative rods** on Gram stain points to severe bacterial infection requiring empiric broad-spectrum intravenous antibiotic coverage targeting gram-negative organisms.
*IV ceftazidime and gentamicin*
- **Ceftazidime** is a **third-generation cephalosporin** with good activity against gram-negative bacteria, including *Pseudomonas*. However, adding **gentamicin**, an **aminoglycoside**, could increase the risk of **nephrotoxicity** in an elderly patient with potential underlying renal impairment due to hypertension and multiple medications, especially when a single agent like cefepime might suffice initially.
- While this combination offers broad gram-negative coverage, **monotherapy with cefepime** is often preferred for empiric treatment of suspected gram-negative sepsis or osteomyelitis to minimize potential adverse effects and simplify treatment, especially in an elderly patient.
*IV vancomycin and ceftazidime*
- **Vancomycin** is primarily used for **gram-positive organisms**, particularly **MRSA**. While it addresses potential *Staphylococcus* infection if gram stain was equivocal or negative, the presence of **gram-negative rods** makes it less critical as an initial empiric therapy for this specific presentation.
- The combination would provide very broad coverage, but the primary pathology involves gram-negative rods, making the inclusion of vancomycin less targeted than alternatives, and risking unnecessary antibiotic exposure while not optimally covering common UTI-related gram-negative pathogens as effectively as cefepime.
*IV vancomycin*
- **Vancomycin** provides excellent coverage for **methicillin-resistant *Staphylococcus aureus* (MRSA)** and other gram-positive organisms, but it has **no activity against gram-negative rods**.
- Since the Gram stain specifically shows **gram-negative rods**, vancomycin monotherapy would be ineffective against the identified pathogen and is therefore an inappropriate choice.
*IV nafcillin*
- **Nafcillin** is a **penicillinase-resistant penicillin** primarily used for **methicillin-sensitive *Staphylococcus aureus* (MSSA)** and other gram-positive infections.
- It has **no significant activity against gram-negative rods**, making it an ineffective treatment option for an infection caused by gram-negative organisms.
Question 52: A 64-year-old woman with a past medical history of poorly managed diabetes presents to the emergency department with nausea and vomiting. Her symptoms started yesterday and have been progressively worsening. She is unable to eat given her symptoms. Her temperature is 102°F (38.9°C), blood pressure is 115/68 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for left-sided costovertebral angle tenderness, and urinalysis demonstrates bacteriuria and pyuria. The patient is admitted to the hospital and started on IV ceftriaxone. On day 3 of her hospital stay she is afebrile, able to eat and drink, and feels better. Which of the following antibiotic regimens should be started or continued as an outpatient upon discharge?
A. Amoxicillin
B. Nitrofurantoin
C. Ciprofloxacin
D. Ceftriaxone
E. Trimethoprim-sulfamethoxazole (Correct Answer)
Explanation: ***Trimethoprim-sulfamethoxazole***
- This patient presents with **acute pyelonephritis**, indicated by fever, CVA tenderness, bacteriuria, and pyuria, requiring a 7-14 day course of treatment.
- After 3 days of IV ceftriaxone with clinical improvement, **step-down to oral therapy** is appropriate.
- **Trimethoprim-sulfamethoxazole** is a first-line oral agent for completing treatment of uncomplicated pyelonephritis and is preferred when **local resistance rates are <20%** and no specific resistance data is available.
- It achieves adequate concentrations in renal tissue and is cost-effective for outpatient therapy.
*Amoxicillin*
- **Amoxicillin** is not recommended for pyelonephritis due to **high resistance rates** among common uropathogens like *E. coli* (often >30%).
- It does not achieve adequate concentrations in the renal parenchyma to effectively treat **upper urinary tract infections**.
*Nitrofurantoin*
- **Nitrofurantoin** is concentrated in the bladder and is highly effective for **lower urinary tract infections (cystitis)**.
- It is **contraindicated for pyelonephritis** because it does not reach therapeutic levels in the renal parenchyma or bloodstream.
- Additionally, it should be avoided in patients with impaired renal function.
*Ciprofloxacin*
- **Ciprofloxacin** is also a first-line oral agent for pyelonephritis and would be an appropriate choice for step-down therapy.
- However, when no culture or susceptibility data is available, **TMP-SMX is generally preferred** as an initial oral choice due to concerns about promoting fluoroquinolone resistance and potential adverse effects (tendonitis, QT prolongation, C. difficile).
- Fluoroquinolones are particularly valuable when reserved for cases with known resistance to other agents or specific patient contraindications.
*Ceftriaxone*
- **Ceftriaxone** is an IV third-generation cephalosporin used for initial empiric treatment of acute pyelonephritis in hospitalized patients.
- Once the patient is **clinically stable, afebrile, and tolerating oral intake**, transitioning to oral therapy is standard practice.
- Continued IV therapy as an outpatient is unnecessarily invasive and costly when oral options are effective.
Question 53: A 51-year-old man presents to his physician’s office with a persistent fever that started a week ago. He says that his temperature ranges between 37.8–39.1°C (100–102.5°F). He has also had a persistent cough productive of foul-smelling sputum. There is no significant medical history to report, but he does mention that he has been suffering from dental caries for the last month. He has been meaning to see his dentist but has been too busy to do so. His blood pressure is 120/70 mm Hg, the respirations are 18/min, and the temperature is 38.5°C (101.3°F). His oxygen saturation is 90% on room air. On examination, he has decreased breath sounds in his right lung field with the presence of soft inspiratory crackles. He is sent to the laboratory for sputum analysis and chest imaging. Based on his history and physical examination, which of the following would be the next best step in the management of this patient?
A. Bronchoscopy
B. Surgical drainage
C. Hospital admission (Correct Answer)
D. Metronidazole
E. Clindamycin
Explanation: ***Hospital admission***
- This patient presents with signs and symptoms suggestive of **aspiration pneumonia** with possible **lung abscess formation**, indicated by persistent fever, foul-smelling sputum, decreased breath sounds, and a history of dental caries. His **low oxygen saturation (90% on room air)** is a significant finding requiring close monitoring and immediate intervention in an inpatient setting.
- Given the severity of his respiratory distress and the potential for rapid deterioration, **hospital admission** is necessary for intravenous antibiotics, respiratory support, and further diagnostic workup, such as a chest CT scan to confirm a lung abscess.
*Bronchoscopy*
- While bronchoscopy can be used for diagnosis and drainage of a lung abscess, it is typically performed *after* initial stabilization and empiric antibiotic therapy in a hospitalized patient.
- It is not the *immediate* next best step given the patient's acute respiratory compromise.
*Surgical drainage*
- Surgical drainage is a more invasive procedure and is reserved for cases where medical management with antibiotics fails, or when there is a very large or complicated abscess.
- It is not the initial treatment strategy for a suspected lung abscess.
*Metronidazole*
- Metronidazole is an antibiotic that covers anaerobic bacteria, which are commonly implicated in aspiration pneumonia and lung abscesses.
- However, it is usually used in combination with other antibiotics (e.g., a beta-lactam) and would be initiated *after* hospital admission and establishment of IV access.
*Clindamycin*
- Clindamycin is an effective antibiotic against anaerobic bacteria and is a common choice for lung abscesses.
- Similar to metronidazole, it would be administered *after* hospital admission as part of the treatment regimen, not as the immediate next step in management.
Question 54: A 37-year-old man with a history of IV drug use presents to the ED with complaints of fevers, chills, and malaise for one week. He admits to recently using IV and intramuscular heroin. Vital signs are as follows: T 40.0 C, HR 120 bpm, BP 110/68 mmHg, RR 14, O2Sat 98%. Examination reveals a new systolic murmur that is loudest at the lower left sternal border. Initial management includes administration of which of the following regimens?
A. IV Vancomycin, IV ceftriaxone, IV fluconazole
B. IV Vancomycin, IV ceftriaxone (Correct Answer)
C. IV Vancomycin, IV levofloxacin
D. IV Vancomycin
E. IV Vancomycin, IV gentamicin, PO rifampin
Explanation: ***IV Vancomycin, IV ceftriaxone***
- The patient's history of **IV drug use**, fevers, chills, new systolic murmur, and likely **tricuspid valve involvement** (murmur loudest at the lower left sternal border) strongly suggest **infective endocarditis**.
- The empiric regimen for suspected endocarditis in an IV drug user should cover **methicillin-resistant _Staphylococcus aureus_ (MRSA)** with **vancomycin** and gram-negative organisms with a **third-generation cephalosporin** like **ceftriaxone**.
- This combination provides broad coverage for the most common pathogens in native valve endocarditis among IV drug users, including MRSA, streptococci, and many gram-negative organisms.
*IV Vancomycin, IV ceftriaxone, IV fluconazole*
- While vancomycin and ceftriaxone are appropriate, **fluconazole** is an antifungal and is generally not indicated for empiric treatment of bacterial endocarditis unless there's a strong suspicion of **fungal infection**.
- Fungal endocarditis is less common and usually requires prolonged treatment with specific antifungals, often alongside surgical intervention.
*IV Vancomycin, IV levofloxacin*
- **Levofloxacin** is a fluoroquinolone that covers a broad spectrum of bacteria but is not the preferred empiric agent for gram-negative coverage in suspected endocarditis in IV drug users due to concerns about resistance and lack of superior coverage compared to third-generation cephalosporins.
- **Ceftriaxone** provides better coverage for common gram-negative pathogens associated with endocarditis among IV drug users in this context.
*IV Vancomycin, IV gentamicin, PO rifampin*
- **Gentamicin** is an aminoglycoside that provides effective gram-negative coverage and is often used in combination therapy for endocarditis, but **rifampin** is typically reserved for prosthetic valve endocarditis or refractory cases due to its risk of drug interactions and resistance development.
- **Oral rifampin** may not be appropriate for initial aggressive treatment in an acutely ill patient with suspected acute endocarditis, where IV therapy is preferred.
*IV Vancomycin*
- While **vancomycin** is crucial for covering **MRSA** which is common in IV drug users, it alone does not provide adequate coverage for potential **gram-negative pathogens** that can also cause endocarditis in this population.
- **Multidrug empiric therapy** is essential to cover a broad range of likely pathogens causing endocarditis in IV drug users, especially with severe symptoms.
Question 55: A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?
A. Intrinsic absence of a target site for the drug
B. Use of an altered metabolic pathway
C. Production of beta-lactamase enzyme (Correct Answer)
D. Altered structural target for the drug
E. Drug efflux pump
Explanation: ***Production of beta-lactamase enzyme***
- The patient's symptoms of a rapidly worsening infection despite ampicillin treatment suggest the presence of a **beta-lactamase producing organism**. Ampicillin is a **beta-lactam antibiotic** that is inactivated by these enzymes.
- Anorectal abscesses and rapidly progressing soft tissue infections are often caused by **polymicrobial flora**, including staphylococci and enterococci, many of which can produce **beta-lactamase**.
*Intrinsic absence of a target site for the drug*
- While some bacteria inherently lack the target site for certain drugs (e.g., mycoplasma lacking a cell wall, thus being resistant to beta-lactams), this is less likely to be the **most common mechanism of acquired resistance** leading to treatment failure in a typical perianal infection.
- The rapid progression and failed initial treatment point towards an **acquired mechanism of resistance** rather than an intrinsic one.
*Use of an altered metabolic pathway*
- This mechanism, such as altered **folate synthesis pathways** in resistance to trimethoprim-sulfamethoxazole, is less common as the primary mechanism for ampicillin resistance.
- Ampicillin's mechanism of action primarily targets the **bacterial cell wall**, not a metabolic pathway in the same way.
*Altered structural target for the drug*
- This involves modifications to the **penicillin-binding proteins (PBPs)**, which are the targets of beta-lactam antibiotics like ampicillin. While a valid mechanism (e.g., in MRSA), the **production of beta-lactamase** is generally a more widespread and common cause of ampicillin failure, especially in infections involving mixed flora from the perianal region.
- Given the abrupt failure of ampicillin, **beta-lactamase inactivation** is a more immediate and common cause than a rapid mutational change in PBPs.
*Drug efflux pump*
- **Efflux pumps** actively remove antibiotics from the bacterial cell, contributing to resistance against various drug classes.
- While efflux pumps can play a role, the dominant mechanism for resistance to **ampicillin** in many common perianal pathogens is the **enzymatic degradation by beta-lactamases**.
Question 56: A 26-year-old immigrant from Mexico presents to your clinic for a physical. He tells you that several weeks ago, he noticed a lesion on his penis which went away after several weeks. It was nontender and did not bother him. He currently does not have any complaints. His temperature is 97.9°F (36.6°C), blood pressure is 139/91 mmHg, pulse is 87/min, respirations are 14/min, and oxygen saturation is 98% on room air. Physical exam is unremarkable and shows no evidence of any rash. A VDRL and FTA-ABS test are both positive. What is the most appropriate management of this patient?
A. Penicillin (Correct Answer)
B. Doxycycline
C. No treatment indicated
D. Acyclovir
E. Azithromycin and ceftriaxone
Explanation: ***Penicillin***
- The patient's history of a **painless genital ulcer** that resolved spontaneously, followed by positive VDRL and FTA-ABS tests, is classic for **syphilis**. Given the VDRL and FTA-ABS are both positive, this indicates a current or treated syphilis infection.
- **Penicillin G** is the drug of choice for all stages of syphilis; the specific formulation (e.g., benzathine penicillin G) and duration depend on the stage of infection.
*Doxycycline*
- **Doxycycline** can be used as an alternative treatment for syphilis in patients with a **penicillin allergy**.
- However, it is not the first-line treatment and there is no indication of a penicillin allergy in this patient.
*No treatment indicated*
- The positive VDRL and FTA-ABS tests definitively confirm an active or recently treated syphilis infection, requiring **treatment**.
- Leaving syphilis untreated can lead to severe complications, including **neurosyphilis** and **cardiovascular syphilis**.
*Acyclovir*
- **Acyclovir** is an antiviral medication used to treat **herpes simplex virus (HSV)** infections, which cause painful genital ulcers, not the painless chancre seen in syphilis.
- It has no efficacy against the bacterial pathogen *Treponema pallidum* that causes syphilis.
*Azithromycin and ceftriaxone*
- The combination of **azithromycin and ceftriaxone** is typically used to treat uncomplicated **gonorrhea** and **chlamydia** simultaneously.
- While these are common sexually transmitted infections, they do not cause the painless chancre or result in the serological findings (positive VDRL and FTA-ABS) characteristic of syphilis.
Question 57: A 51-year-old man comes to the physician because of a 1-day history of progressive pain, excessive tearing, and blurry vision of his right eye. He first noticed his symptoms last evening while he was watching a movie at a theater. His left eye is asymptomatic. He wears contact lenses. He has atopic dermatitis treated with topical hydrocortisone. His temperature is 37°C (98.6°F), pulse is 85/min, and blood pressure is 135/75 mm Hg. Examination shows a visual acuity in the left eye of 20/25 and 20/40 in the right eye. The right eye shows conjunctival injection and an edematous cornea with a whitish exudate at the bottom of the anterior chamber. Fluorescein staining shows a round corneal infiltrate. Which of the following is the most appropriate pharmacotherapy?
A. Topical prednisolone
B. Topical ganciclovir
C. Topical ketorolac and artificial tears
D. Topical timolol and pilocarpine
E. Topical ofloxacin (Correct Answer)
Explanation: ***Topical ofloxacin***
- The patient's symptoms (pain, tearing, blurry vision in one eye, conjunctival injection, edematous cornea, whitish exudate in the anterior chamber, and a round corneal infiltrate with fluorescein staining) are highly suggestive of **bacterial keratitis**, likely due to contact lens use.
- **Topical fluoroquinolones** like ofloxacin are the first-line treatment for bacterial keratitis due to their broad-spectrum activity and excellent corneal penetration.
*Topical prednisolone*
- **Corticosteroids** are generally contraindicated in active infectious keratitis, especially bacterial, viral, or fungal infections, as they can worsen the infection and delay healing.
- While sometimes used in severe, non-infectious inflammatory conditions, their use here would be inappropriate and potentially harmful.
*Topical ganciclovir*
- **Ganciclovir** is an antiviral agent used to treat herpes simplex keratitis (HSK) or other viral keratitis.
- The clinical presentation with a **round corneal infiltrate** is more typical of bacterial keratitis, whereas HSK often presents with a characteristic **dendritic ulcer** pattern, which is not described.
*Topical ketorolac and artificial tears*
- **Ketorolac** is a non-steroidal anti-inflammatory drug (NSAID) which can help with pain and inflammation but does not address the underlying bacterial infection.
- **Artificial tears** provide symptomatic relief for dry eyes but have no role in treating infectious keratitis and would not resolve the patient's condition.
*Topical timolol and pilocarpine*
- **Timolol** is a beta-blocker that reduces intraocular pressure, and **pilocarpine** is a miotic agent and also reduces intraocular pressure, used primarily in glaucoma.
- These medications are not indicated for the treatment of infectious keratitis and would not address the bacterial cause of the patient's symptoms.
Question 58: A 36-year-old woman comes to the emergency department because of an itchy lesion on her skin. The rash developed shortly after she took an antibiotic for a urinary tract infection. Her temperature is 37.5°C (99.3°F), pulse is 99/min, and blood pressure is 100/66 mm Hg. Physical examination shows swelling of the face and raised, erythematous plaques on her trunk and extremities. Which of the following is the most likely cause of this patient's current condition?
A. Deficiency of C1 inhibitor
B. Secretion of cytokines by T cells
C. Deposition of immune complexes
D. Release of a vasoactive amine (Correct Answer)
E. Activation of complement cascade
Explanation: ***Release of a vasoactive amine***
- The rapid onset of **urticaria (itchy, erythematous plaques)** and **angioedema (facial swelling)** after antibiotic exposure points to a **Type I hypersensitivity (IgE-mediated) reaction**.
- This reaction is characterized by the release of **histamine** and other vasoactive amines from mast cells and basophils, leading to capillary dilation, increased vascular permeability, and the observed symptoms.
*Deficiency of C1 inhibitor*
- A deficiency in **C1 inhibitor** causes **hereditary angioedema**, which typically presents with recurrent episodes of swelling but **without urticaria or itching**, as bradykinin, not histamine, is the primary mediator.
- The episodes are often triggered by trauma or stress and are not typically associated with drug-induced allergic reactions in this manner.
*Secretion of cytokines by T cells*
- Secretion of cytokines by T cells (e.g., in a **Type IV hypersensitivity reaction**) generally causes a **delayed-type hypersensitivity**, manifesting as contact dermatitis or drug rash that appears days after exposure.
- This mechanism would not explain the rapid onset of urticaria and angioedema observed just after antibiotic intake.
*Deposition of immune complexes*
- **Immune complex deposition** (a **Type III hypersensitivity reaction**) can cause conditions like serum sickness or vasculitis, which typically present with fever, arthralgia, and a rash that is often purpuric or palpable, not an itchy, transient urticarial rash.
- The onset of symptoms in Type III reactions is usually hours to days after exposure, not immediately post-ingestion.
*Activation of complement cascade*
- While complement activation can occur in various immune reactions, it is primarily central to **Type II (cytotoxic)** and **Type III (immune complex)** hypersensitivity.
- Although it plays a role in enhancing inflammation, it is not the primary mechanism responsible for the immediate release of vasoactive amines in an **IgE-mediated allergic reaction** leading to urticaria and angioedema.
Question 59: Six days after undergoing an elective hip replacement surgery, a 79-year-old man develops dysuria, flank pain, and fever. His temperature is 38.5°C (101.3°F). Examination shows marked tenderness in the right costovertebral area. Treatment with an antibiotic is begun, but his symptoms do not improve. Further evaluation shows that the causal organism produces an enzyme that inactivates the antibiotic via phosphorylation. An agent from which of the following classes of antibiotics was most likely administered?
A. Macrolides
B. Tetracyclines
C. Aminoglycosides (Correct Answer)
D. Glycopeptides
E. Fluoroquinolones
Explanation: ***Aminoglycosides***
- **Aminoglycosides** are commonly inactivated by bacterial enzymes through **phosphorylation**, acetylation, or adenylation, leading to resistance.
- The patient's lack of improvement despite antibiotic treatment and the mechanism of inactivation point towards this class of antibiotics.
*Macrolides*
- **Macrolide resistance** typically involves mechanisms such as modification of the ribosomal binding site (e.g., methylation), drug efflux pumps, or enzymatic inactivation by esterases, not phosphorylation.
- While macrolides can treat various infections, their inactivation mechanism is different from what is described.
*Tetracyclines*
- **Tetracycline resistance** is primarily mediated by bacterial efflux pumps that actively transport the antibiotic out of the cell, or by ribosomal protection proteins that interfere with drug binding.
- **Enzymatic inactivation via phosphorylation** is not a characteristic resistance mechanism for tetracyclines.
*Glycopeptides*
- **Glycopeptide resistance**, particularly to vancomycin, is mainly associated with alterations in the cell wall precursor target (e.g., D-Ala-D-Lac modification), which prevents the antibiotic from binding.
- This mechanism is distinct from enzymatic phosphorylation of the antibiotic molecule itself.
*Fluoroquinolones*
- **Fluoroquinolone resistance** primarily arises from mutations in the genes encoding bacterial DNA gyrase and topoisomerase IV, or via efflux pumps.
- There is no significant mechanism of resistance involving direct enzymatic phosphorylation of fluoroquinolone drugs.
Question 60: A 51-year-old man with alcohol use disorder comes to the physician because of a fever and productive cough. An x-ray of the chest shows a right lower lobe consolidation and a diagnosis of aspiration pneumonia is made. The physician prescribes a drug that blocks peptide transfer by binding to the 50S ribosomal subunit. Which of the following drugs was most likely prescribed?
A. Ceftriaxone
B. Doxycycline
C. Metronidazole
D. Clindamycin (Correct Answer)
E. Azithromycin
Explanation: ***Clindamycin***
- **Clindamycin** is a lincosamide antibiotic that **blocks peptide transfer** by binding to the **50S ribosomal subunit**, inhibiting bacterial protein synthesis.
- It is a highly effective treatment for **aspiration pneumonia** due to its excellent activity against the **anaerobic bacteria** commonly found in oral flora, which are the primary pathogens in this condition.
*Ceftriaxone*
- **Ceftriaxone** is a third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to **penicillin-binding proteins**, not the 50S ribosomal subunit.
- While it has broad-spectrum activity, it is typically used for community-acquired pneumonia and is less effective against the **anaerobic organisms** predominant in aspiration pneumonia.
*Doxycycline*
- **Doxycycline** is a tetracycline antibiotic that binds to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA.
- While effective against some respiratory pathogens, it is not the first-line choice for **aspiration pneumonia** as its anaerobic coverage is insufficient.
*Metronidazole*
- **Metronidazole** acts by forming **cytotoxic compounds** that damage bacterial DNA after reduction by anaerobic enzymes, rather than binding to ribosomal subunits.
- While effective against many **anaerobes**, it is often used in combination with other antibiotics for aspiration pneumonia, and its mechanism of action is distinct from that described.
*Azithromycin*
- **Azithromycin** is a macrolide antibiotic that also binds to the **50S ribosomal subunit**, but it **inhibits translocation** of the growing peptide chain, not primarily peptide transfer.
- While used for community-acquired pneumonia, its coverage for **oropharyngeal anaerobes** can be inconsistent, making clindamycin a more reliable choice for aspiration pneumonia.
